StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > .16 a share. SZLS isn’t alone in unrealized potential.

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Jun 08, 2022 4:57pm

73 Views

Post# 34741712

RE:RE:.16 a share. SZLS isn’t alone in unrealized potential.

If I had cancer and this works, sign me up, capital appreciation on our houses would cover the cost. Also price comes down with volume required.

Nailbiter1 wrote: Administered every 3 weeks for 6 months
Ain't that around $200k for the treatment?
Fine if you are a big billion dollar capitalist
like Mykndrsn but for us wee folk...
Shoot me in da face.